Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Research

Encephalitis, Ontario, Canada, 2002–2013

Alyssa S. Parpia1, Ye Li, Cynthia Chen, Badal Dhar, and Natasha S. CrowcroftComments to Author 
Author affiliations: Public Health Ontario, Toronto, Ontario, Canada (A.S. Parpia, Y. Li, C. Chen, B. Dhar, N.S. Crowcroft); University of Toronto, Toronto (A.S. Parpia, Y. Li, N.S. Crowcroft)

Main Article

Table 4

Multiple linear regression modeling association between log-transformed length of hospitalization and category of encephalitis cause, Ontario, Canada, 2002–2013

Variable* No. (%) cases Mean length of hospitalization, d (median) Exponentiated β-coefficient (95% CI) t p value
Intercept
8.9 (8.0–9.8)
41.0
<0.0001
Encephalitis cause
Viral 1,788 (27.7) 27.36 (14)
Bacterial 152 (2.4) 27.45 (19) 1.2 (1.0–1.4) 1.5 0.128
Amebic/parasitic/fungal 92 (1.4) 43.17 (18) 1.3 (1.0–1.6) 2.1 0.038
Immune mediated 657 (10.2) 26.37 (14) 1.1 (1.0–1.2) 1.8 0.0804
Other 466 (7.2) 24.33 (11) 0.9 (0.8–1.0) −1.7 0.0817
Unknown 3,299 (51.0) 19.79 (9) 0.8 (0.7–0.8) −7.8 <0.0001
Unable to classify
9 (0.1)
38.78 (16)
2.1 (1.0–4.1)
2.0
0.0448
Sex
M 3,417 (52.8) 23.07 (11)
F
3,046 (47.1)
23.82 (12)
1.0 (1.0–1.1)
0.9
0.3634
Age group, y
<1 173 (2.7) 22.83 (16) 1.0 (0.8–1.1) −0.6 0.55
1–4 377 (5.8) 12.28 (5) 0.6 (0.5–0.7) −8.6 <0.0001
5–19 915 (14.2) 14.54 (6) 0.8 (0.8–0.9) −8.4 <0.0001
20–44 1,486 (23.0) 23.27 (9) 0.8 (0.8–0.9) −3.6 0.0003
45–64 1,823 (28.2) 25.02 (13)
>65
1,689 (26.1)
29.19 (17)
1.1 (1.1–1.2)
3.7
0.0003
Immune status
Immunocompetent 5,525 (85.5) 21.29 (10)
Immunocompromised
938 (14.5)
35.99 (19)
1.3 (1.2–1.4)
5.6
<0.0001
Co-morbidity level†
None 3718 (57.5) 14.05 (8)
Low 564 (8.7) 26.08 (14) 1.7 (1.6–1.9) 11.0 <0.0001
Moderate 911 (14.1) 26.13 (15) 1.8 (1.7–2.0) 14.8 <0.0001
High 575 (8.9) 39.00 (25) 2.8 (2.6–3.1) 21.2 <0.0001
Very high 520 (8.1) 55.28 (36) 4.0 (3.6–4.4) 27.0 <0.0001
Missing data 175 (2.7) 14.05 (41) 4.4 (3.7–5.2) 17.9 <0.0001

*Season, year, and patient Local Health Integration Network were not found to cause a significant change (>20%) in the parameter estimates for the exposure variable (category of encephalitis cause) and were thus excluded from the mode.
†Case mix grouping plus comorbidity levels are based on cumulative cost impact of comorbidities on patient stay, where "none" represents no impact and "very high” represents the greatest impact.

Main Article

1Current affiliation: Yale School of Public Health, New Haven, Connecticut, USA.

Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external